Kemwell Appoints Dr. Ninad Deshpanday to Head Global R&D PR Newswire BANGALORE, February 15, 2013 BANGALORE, February 15, 2013 /PRNewswire/ -- Kemwell Biopharma Pvt. Ltd, a global pharmaceutical contract development and manufacturing company, announced that it has appointed Dr. Ninad Deshpanday as President of Research and Development. Anurag Bagaria, Chairman and Managing Director of Kemwell said, "Dr. Deshpanday brings a unique combination of leadership skills and technical expertise in pharmaceutical development, as well as excellent business development skills with a very strong network of customers in the US, Europe and Asia. He will spearhead the R&D business for Kemwell as we continue to grow the geographical footprint and strategically position Kemwell into a leading Global Contract Services Provider." Dr. Deshpanday has over 22 years' experience of diverse international experience in the pharmaceutical industry (US + India). This includes pharmaceutical development activities for NDAs, specialty drug delivery based 505(b)(2) products, including Oral and Transdermal, and complex Generic products, with several F2Fs and PIVs. He also has rich experience in Technical and Business Development Prior to joining Kemwell, he was President of Pharmaceutical R&D at Lupin, in Pune, India since Nov. 2007, with leadership responsibilities for formulations, analytical, and BA/BE activities. Before joining Lupin, Dr. Deshpanday was Vice President of Business Development at AAIPharma in RTP, NC, with responsibilities for sales and marketing activities for their CM&C functions; Vice President for Drug Product Development for Synta Pharmaceuticals, with responsibilities for all CM&C activities; andTechnical Business Director for the Pharmaceutics division of Cardinal Health. Dr. Deshpanday earned his Doctorate in Pharmaceutics from the University of S. Carolina in 1990, and has an M. Pharm. and B. Pharm. from LM College of Pharmacy in Ahmedabad, India. About Kemwell Biopharma Pvt. Ltd. Kemwell Biopharma Pvt. Ltd, headquartered in Bangalore, India is a pure-play global contract development and manufacturing company. The company manufactures and develops pharmaceuticals for some of the world's top pharmaceutical companies, including GlaxoSmithKline, Bayer, Novartis and Pfizer. Kemwell is one of India's largest contract manufacturers of pharmaceuticals with over 30 years' experience. The company employs more than 1000 employees worldwide and has seven production facilities, five in India and two in Sweden. Kemwell is an approved pharmaceutical manufacturer in over 80 countries including the American, European, Japanese and Indian markets. Read more about Kemwell on www.kemwellbiopharma.com . Primary Media Contact: Karan Bagaria, firstname.lastname@example.org , 91-80-39286200 Secondary Media Contact: Bhaskar Viswanathan, email@example.com , 91-80-39286200 Contact: PRN
Tesco Falls as Much as 11.8% After Saying Profit Overstated
Kemwell Appoints Dr. Ninad Deshpanday to Head Global R&D
Press spacebar to pause and continue. Press esc to stop.